Cargando…
SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN
The existing biomarkers are insufficient for predicting the prognosis of pancreatic ductal adenocarcinoma (PDAC). Intraductal papillary mucinous neoplasm (IPMN) is a precursor to PDAC; therefore, identifying biomarkers from differentially expressed genes (DEGs) of PDAC and IPMN is a new and reliable...
Autores principales: | Zhang, Chuan-long, Shen, Qian, Liu, Fu-dong, Yang, Fan, Gao, Meng-qi, Jiang, Xiao-chen, Li, Yi, Zhang, Xi-yuan, En, Ge-er, Pan, Xue, Pang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618477/ https://www.ncbi.nlm.nih.gov/pubmed/37907515 http://dx.doi.org/10.1038/s41598-023-44646-x |
Ejemplares similares
-
LHPP Inhibits the Viability, Migration, and Proliferation of PDAC Cells and Significantly Affects the Expression of SDC1 and S100p
por: Xia, Zhaozhi, et al.
Publicado: (2023) -
Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Gregori, Alessandro, et al.
Publicado: (2023) -
Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma
por: Feng, Chen, et al.
Publicado: (2020) -
Clinicopathological and prognostic significance of SDC1 overexpression in breast cancer
por: Cui, Xiangrong, et al.
Publicado: (2017) -
AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017)